Cardiovascular risk and mortality between IJAK or tocilizumab compared to Anti-TNF in patients with rheumatoid arthritis: results of a systematic review and a meta-analysis in a conventional and Bayesian network

"Cardiovascular risk and mortality between IJAK or tocilizumab compared to Anti-TNF in patients with rheumatoid arthritis: results of a systematic review and a meta-analysis in a conventional and Bayesian network" (Doctorate). Candidate: Alisson Aliel Viganô Pugliesi. Advisor: professor Manoel Barros Bertolo. November 24, 2023, at 9 am, at the FCM Postgraduate Course.

twitter_icofacebook_ico